We would love to hear your thoughts about our site and services, please take our survey here.
Shredz
@Shredz90
https://twitter.com/Shredz90/status/1353417985520758784?s=20
Share price is 89p at.mcap of 160m but should be double that so £1.90
I think the Avacta share holders are scared.for some reason
Or they wouldn't be posting so much on our board trying to sell it to us
i think the Avacta crowd are missing the point i too am invested in Avacta.
its not about Avactas test being better than Mologics as their both miles ahead of innova but its about whats available at the time.
if Avacta do not have a test the goverment.may well run with the Mologic one either temporarily or for good depending on impact.
Proof of this is INNOVA rubbish test but billions spend on it because that wasnthe best at the TIME.
Mate go back to Avacta and spirit your rubbish there
Fact is if Avacta don't pull their finger out the Goverment will pick the next best test they don't care about false positives weighed next to an increase in infection rates time will show who's right and who's wrong.
Free act is this share has growth up to £2.60 I doubt Avact will move past £4 and take a year to get there.
The smart money would be to invest everything in omega then put back in Avacta should they ever get a test
Could you tell me what other revenue streams Ablington have other than Covid tests?
This is reason the rise was low by which is obvious to everyone. What isn't is finncap holding the company share price back hopefully they will cover this in their morning meeting and we may see an increase.
Sold Value £678.44k
Vol. Bought 632,439
Bought Value £581.84k
I'm convinced both Abingdon Health and Omega have the same price.profile and this needs to be addressed as we are becoming bigger than Ablington.
Go on then!!
The delay of TT was proberly the different variants and making sure the tests picked them up at a guess like
I personally think it was done on purpose so friends and family could get in before the real BOOM
I would say he's learned his lesson by the way the last RNS worded may I dare say they have someone else writing them??
Then we should see £2.60 easy as it's becoming apparent to me a huge order could soon be in the way because why else would they be stockpiling their antigen tests 250 staff doing something.
One positive in that is on a drop it doesn't. Ever drop silly amounts but no more drops now it's going to be good news after good news
No Sharpe rises due to current mcap and number of shares.
It's already risen 1200% in year it will be contracts that get this baby moving and their on their way
Avacta test has no CE no CV mologic do so which test do you think is going to get rolled out??
It's a no brainer it's what's available at the time like they used Innova they will now use omega
Computer909
Twatcher
JAdam
For newbies to filter so don't have to listen to their deramping nonsense
Buy your clearly not invested
Is the contract renewable : no- because new purchase system they have to reapply just a formality for each QTR.
Is the contract split into lots no- it's not they reapply every QTR dur
Total value : min 50m max 374m nope contracts been updated to say £374 on Bidstats I wonder why????
Massive profit margins if if 50% that's £26 a test